Pharmaceutical Manufacturer / API Supplier
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract entails the manufacture and supply of Cefazolin Injection in bulk form, requiring full-end-to-end pharmaceutical production including sourcing of the active pharmaceutical ingredient, sterile formulation, aseptic filling, and rigorous quality control processes. All activities must comply with stringent FDA regulations and Department of Defense standards to ensure product safety, potency, and consistency for military medical use. The work is classified as a subcontract under NAICS code 325412, with the Defense Logistics Agency acting as the contracting organization on behalf of the Department of Defense. Production and performance are expected to meet federal pharmaceutical manufacturing requirements without geographic restriction indicated, though the delivery and distribution logistics are tied to DoD supply chain protocols. The contract was posted in July 2026 and is linked to a specific award reference, indicating it is part of an ongoing procurement initiative to secure reliable, high-quality antibiotic supplies for defense medical operations.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
This scope was carved out of SPE2D9-26-F-7392.
The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.
CEFAZOLIN INJECTION
AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
